ArriVent BioPharma Stock Quote AVBP - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

15.44

Bid

9.88

Ask

23.11

Volume

53,529

15.36 Day's Range 16.48

14.35 52 Week Range 25.5076

Market Cap

493.411M

Previous Close

15.54

Open

15.70

Last Trade

15.44

Last Trade Time

Financial Volume

$ 849,153

VWAP

15.8634

Average Volume (3m)

193,080

Shares Outstanding

31,956,657

Dividend Yield

PE Ratio

-7.12

Earnings Per Share (EPS)

-2.17

Revenue

Net Profit

-69.33M

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therap... ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

arrivent.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

ArriVent BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVBP. The last closing price for ArriVent BioPharma was $15.54. Over the last year, ArriVent BioPharma shares have traded in a share price range of $ 14.35 to $ 25.5076.

ArriVent BioPharma currently has 31,956,657 shares outstanding. The market capitalization of ArriVent BioPharma is $493.41 million. ArriVent BioPharma has a price to earnings ratio (PE ratio) of -7.12.

ArriVent Appoints Kristine Peterson to its Board of Directors

NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical...

ArriVent BioPharma Reports Full Year 2023 Financial Results

Company progresses the development of furmonertinib with a data readout planned for 2024Furmonertinib granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration Completed...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.129701686122	15.42	16.65	14.35	87175	15.60404921	CS
4	-2.48	-13.8392857143	17.92	19.11	14.35	158551	16.72508506	CS
12	-6.53	-29.7223486573	21.97	23.1266	14.35	193080	18.96617687	CS
26	-8.56	-35.6666666667	24	25.5076	14.35	219130	19.26785635	CS
52	-8.56	-35.6666666667	24	25.5076	14.35	219130	19.26785635	CS
156	-8.56	-35.6666666667	24	25.5076	14.35	219130	19.26785635	CS
260	-8.56	-35.6666666667	24	25.5076	14.35	219130	19.26785635	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M